17a-Hydroxyprogesterone Production Cost Reports

The report provides a detailed analysis essential for establishing a 17α-Hydroxyprogesterone production plant. It encompasses all critical aspects necessary for 17α-Hydroxyprogesterone production, including the cost of 17α-Hydroxyprogesterone production, 17α-Hydroxyprogesterone plant cost, 17α-Hydroxyprogesterone production costs, and the overall 17α-Hydroxyprogesterone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a 17α-Hydroxyprogesterone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

17α-Hydroxyprogesterone (17-OHP) is a naturally occurring endogenous steroid hormone that plays a major role in the production of other important hormones like cortisol and androgens. It is mainly used in the medical field for diagnosing and monitoring certain hormone-related conditions. It also acts as a steroid intermediate for synthesising glucocorticoids (e.g., cortisol, dexamethasone). It is also used in the screening and treatment of congenital adrenal hyperplasia (CAH), which is a disorder that affects hormone production in the adrenal glands. It is also used as a reference marker in blood tests to evaluate adrenal and ovarian function. It is often used as a reference marker in blood tests to check for hormone-related disorders, support fertility evaluations, and monitor treatment progress in patients with adrenal issues. Moreover, it is also used in research settings to help scientists study hormone pathways and develop improved diagnostic methods.

The demand for 17α-Hydroxyprogesterone is mainly driven by its use as a natural hormone marker in both clinical testing and hormone-related research, which significantly supports its market growth. Its application in screening for congenital adrenal hyperplasia, a condition where hormone production is affected, also boosts its demand in the medical and diagnostic sectors. Its usage as a biomarker in diagnostics, such as blood tests to evaluate adrenal and ovarian function, further promotes its demand in the healthcare and medical diagnostics centres.

Its demand in hormone diagnostics, research, and the production of steroid-based medicines also contributes to its market expansion. Its involvement as an intermediate in the synthesis of corticosteroids and other therapeutic hormones also increases its demand in the pharmaceutical industry. Industrial 17α-Hydroxyprogesterone procurement is influenced by several factors, including the availability and quality of raw materials, compliance with strict pharmaceutical regulations, and adherence to safety and environmental standards. Production efficiency, process optimisation, supplier consistency, and controlled supply chains also play a major role in shaping its procurement decisions.

Raw Material for 17α-Hydroxyprogesterone Production

According to the 17α-Hydroxyprogesterone production plant project report, the major raw materials for 17α-Hydroxyprogesterone production include Diosgenin, Dehydropregnenolone, Hydrogen Peroxide, Formic Acid, and Aluminium Isopropylate.

Production Process of 17α-Hydroxyprogesterone

The extensive 17α-Hydroxyprogesterone production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of 17α-Hydroxyprogesterone begins with dehydropregnenolone, which itself is obtained from diosgenin, a plant-derived steroid extracted from Dioscorea species, through controlled degradation and oxidation of its side chain. In this method, dehydropregnenolone is first subjected to oxidation of the double bond at the C16–C17 position using hydrogen peroxide in the presence of a base, forming an epoxide intermediate. Then, this epoxide is treated with hydrogen bromide in acetic acid to produce a bromohydrin. The hydroxyl group at the C3 position of the steroid nucleus is further protected by formylation using formic acid, followed by catalytic hydrogenation over palladium to remove the bromine. The hydroxyl group at C17 is then acylated using acetic anhydride. The hydroxyl group at C17 is acylated using acetic anhydride. Then, the C3 protecting group is removed with aluminium isopropylate in cyclohexanone, which causes the double bond to shift to C4–C5 and give 17α-Hydroxyprogesterone as the final product.

17α-Hydroxyprogesterone is a naturally occurring steroidal progestin derived from progesterone and is commonly used as a solid pharmaceutical intermediate. It appears as a white to almost white crystalline powder and is generally odourless in nature. The molecular formula of the compound is C21H30O3, and its molar mass is approximately 330.46 g/mol. The density of the compound is around 1.14 g/cm³. It is practically insoluble in water but shows good solubility in organic solvents such as ethanol, acetone, chloroform, and methanol. Its solubility in water is around 5.056 mg/L (20 degree Celsius). The melting point of 17α-hydroxyprogesterone is in the range of about 220–224 degree Celsius, with decomposition occurring upon further heating. It has no flash point due to its solid steroidal structure and thermal instability at elevated temperatures. Its chemical structure contains both ketone and hydroxyl functional groups, which contribute to its weakly polar character and reactivity in esterification and oxidation reactions.